Faculty of Biology, Medicine and Health

The University of Manchester

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities

  Characterising the role of cell-cell adhesion in melanoma development

Prof C Wellbrock  Applications accepted all year round  Self-Funded PhD Students Only

About the Project

Malignant melanoma accounts for over 85% of all skin cancer deaths, mainly due to resistance against conventional chemotherapies and an early acquisition of invasive behaviour. During melanoma development transformed cells display an altered communication with their microenvironment and adopt changes in adhesion-dependent differentiation, proliferation, survival and motility. This facilitates uncontrolled tumour cell proliferation within the epidermis, invasion into the dermis and eventually colonisation to distant sites.

In order to dissect signalling events relevant for melanoma cell invasion, we have investigated the role of cadherins and catenins because they are main regulators of cell-cell adhesion and interactions with the extracellular environment. We discovered novel roles for beta-catenin and p120-catenin in melanoma cell proliferation and invasion and now want to further characterise their function in melanoma development. This includes studying their interaction with different cadherins (E-cadherin in normal cells, N-cadherin in invasive cells), dissecting the mechanism by which they regulate proliferation, and how they contribute to cell survival when cells cannot make cell-cell contact (a situation found when cells disseminate and give rise to circulating tumour cells and distant metastasis). If we can better understand how these proteins function, we can identify drugs that will allow interfering with their role in melanoma development.

The project will use cell signalling inhibitors and RNAi approaches in cell-culture, and live-cell imaging in three-dimensional (3D) culture systems and in vivo in zebrafish models, where cell invasion, dissemination into the bloodstream and distant seeding of cancer cells can be visualized. Overall, the project provides a unique opportunity to acquire knowledge in a wide range of protein-biochemical, cell-biological and imaging techniques related to translational cancer research.

Funding Notes

This project has a Band 2 fee. Details of our different fee bands can be found on our website. For information on how to apply for this project, please visit the Faculty of Biology, Medicine and Health Doctoral Academy website. Informal enquiries may be made directly to the primary supervisor.

References

1.Gray-Schopfer V, Wellbrock C, Marais R (2007). Melanoma biology and new targeted therapy. Nature.;445(7130):851-7

2. Wellbrock C, Hurlstone A. (2010) BRAF as therapeutic target in melanoma. Biochem Pharmacol.;80(5):561-7

3. Arozarena I, Bischof H, Gilby D, Belloni B, Dummer R, Wellbrock C. (2011) In
melanoma, beta-catenin is a suppressor of invasion. Oncogene;30(45):4531-43

4. Ferguson J, Arozarena I, Ehrhardt M, Wellbrock C. (2012) Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion. Oncogene, Feb 6. [Epub ahead of print] PubMed PMID: 22310287


Where will I study?

Faculty of Biology, Medicine and Health

Tackle real world challenges, make a difference, and elevate your career with postgraduate research in the Faculty of Biology, Medicine and Health at Manchester. From biochemistry to neuroscience, cancer sciences to medicine, audiology to mental health and everything in between, we offer a wide range of postgraduate research projects, programmes and funding which will allow you to immerse yourself in an area of research you’re passionate about.

Why study at the Faculty of Biology, Medicine and Health?

Experience PhD life as part of a diverse postgraduate research community of more than 1,000 postgraduate researchers at the 29th most international university in the world (Times Higher Education, 2023).

Ranked the best place to live in the UK (The Economist Global Liveability Index, 2022), Manchester boasts world-class culture, iconic sports, a thriving music and food scene, and much more. It's not just a place to research, it's a place to call home.

With 93% of research activity at the University rated as 'world-leading' or 'internationally excellent' (Research Excellence Framework, 2021), you'll get the chance to have an impact on global health and science challenges.

1000+

postgraduate students

6th

in the UK - QS (2025)

Manchester  United Kingdom

main campus

About the Faculty of Biology, Medicine and Health

At Manchester, postgraduate researchers are at the heart of our mission to tackle pressing global challenges in biological, medical and healthcare sciences - and you could be too.

By choosing Manchester for your postgraduate research, you’ll be joining a university with an exceptional research reputation, where 93% of research is world-leading or internationally excellent (REF, 2021) and where your work will have real-world impact.

You’ll research in world-class facilities alongside leading experts at the forefront of innovation, collaborating across disciplines to pioneer new treatments, advance scientific knowledge, and improve healthcare globally.

Supported by our dedicated Doctoral Academy and strong industry links, you'll experience PhD life in a vibrant, welcoming and diverse postgraduate research community.

And you’ll leave with the specialist knowledge, research experience and transferable skills that will shape your future in academia, research or industry.


Main campus

The University of Manchester

Manchester

North West

United Kingdom

PhD saved sucessfully